We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific publishing, Laura worked at the Wellcome Sanger Institute and GW Pharma.
Molly Campbell is a senior science writer at Technology Networks. She holds a first-class honors degree in neuroscience. In 2021 Molly was shortlisted for the Women in Journalism Georgina Henry Award.
Cancer is the term used to describe an incredibly complex group of diseases, caused by changes to the genes in one cell or a group of cells. These genetic alternations disrupt the normal functioning of the cell/s giving rise to several phenotypic changes or “hallmarks” that distinguish them from “healthy” cells in the body.
Download this infographic to discover:
The genetics of cancer
The predictive and diagnostic power of genetic-based tools
How sequencing techniques can be used to study cancer
How genetics has fueled the development of precision medicines
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific publishing, Laura worked at the Wellcome Sanger Institute and GW Pharma.
Molly Campbell is a senior science writer at Technology Networks. She holds a first-class honors degree in neuroscience. In 2021 Molly was shortlisted for the Women in Journalism Georgina Henry Award.